Literature DB >> 10610181

Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

P D Côté1, H Moukhles, M Lindenbaum, S Carbonetto.   

Abstract

Mutations in the dystrophin gene (DMD) and in genes encoding several dystrophin-associated proteins result in Duchenne and other forms of muscular dystrophy. alpha-Dystroglycan (Dg) binds to laminins in the basement membrane surrounding each myofibre and docks with beta-Dg, a transmembrane protein, which in turn interacts with dystrophin or utrophin in the subplasmalemmal cytoskeleton. alpha- and beta-Dgs are thought to form the functional core of a larger complex of proteins extending from the basement membrane to the intracellular cytoskeleton, which serves as a superstructure necessary for sarcolemmal integrity. Dgs have also been implicated in the formation of synaptic densities of acetylcholine receptors (AChRs) on skeletal muscle. Here we report that chimaeric mice generated with ES cells targeted for both Dg alleles have skeletal muscles essentially devoid of Dgs and develop a progressive muscle pathology with changes emblematic of muscular dystrophies in humans. In addition, many neuromuscular junctions are disrupted in these mice. The ultrastructure of basement membranes and the deposition of laminin within them, however, appears unaffected in Dg-deficient muscles. We conclude that Dgs are necessary for myofibre survival and synapse differentiation or stability, but not for the formation of the muscle basement membrane, and that Dgs may have more than a purely structural function in maintaining muscle integrity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610181     DOI: 10.1038/15519

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  64 in total

Review 1.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

3.  Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

Authors:  Karim Hnia; Gerald Hugon; François Rivier; Ahmed Masmoudi; Jacques Mercier; Dominique Mornet
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  Complete deletion of all alpha-dystrobrevin isoforms does not reveal new neuromuscular junction phenotype.

Authors:  Dongqing Wang; Bridget B Kelly; Douglas E Albrecht; Marvin E Adams; Stanley C Froehner; Guoping Feng
Journal:  Gene Expr       Date:  2007

5.  Differential requirement for MuSK and dystroglycan in generating patterns of neuromuscular innervation.

Authors:  Julie L Lefebvre; Lili Jing; Sara Becaficco; Clara Franzini-Armstrong; Michael Granato
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

6.  A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering.

Authors:  Joanna Kahl; James T Campanelli
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.

Authors:  Jessica D Gumerson; Carol S Davis; Zhyldyz T Kabaeva; John M Hayes; Susan V Brooks; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2012-12-06       Impact factor: 6.150

8.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

Review 9.  Animal models for genetic neuromuscular diseases.

Authors:  Mariz Vainzof; Danielle Ayub-Guerrieri; Paula C G Onofre; Poliana C M Martins; Vanessa F Lopes; Dinorah Zilberztajn; Lucas S Maia; Karen Sell; Lydia U Yamamoto
Journal:  J Mol Neurosci       Date:  2008-01-18       Impact factor: 3.444

10.  Dystroglycan, a scaffold for the ERK-MAP kinase cascade.

Authors:  Heather J Spence; Amardeep S Dhillon; Marian James; Steven J Winder
Journal:  EMBO Rep       Date:  2004-04-08       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.